Dr. Stephanie Finzel studied medicine at the Friedrich-Alexander-University of Erlangen-Nuremberg in Germany. After finishing her recidency, she joined the Department of Rheumatology at the University of Freiburg as a Senior Attending Physician.

Her main focus is the detection of periarticular bone changes in early and established inflammatory arthritis via musculoskeletal ultrasound (MSUS) and high-resolution peripheral quantitative computed tomography (HR-pQCT).

Stephanie was a fellow for the OMERACT ultrasound workshop in 2012 and is now an established member of the ultrasound workshop. She is a founding member of the SPECTRA-group, and a chairperson of SPECTRA (Europe).

Her aim is to support the validation process of both imaging techniques as outcome parameters in rheumatology clinical trials according to the methodology and regularities of OMERACT. As head of the Clinical Trials Unit Rheumatology she increasingly focusses on translational aspects of rheumatology and immunology.